Tim HayesPharmaceuticalsNovartis to Triple Biosimilar Offering by 2020Swiss-based pharmaceutical company Novartis aims to increase its number of biosimilar drugs on the market by 2020.June 22, 2016PharmaceuticalsHillary’s Pharma Donations Dwarf RivalsHillary Clinton has raised more money from the top 15 drug companies than all Republican nominees combined.June 21, 2016PharmaceuticalsNew Medical Device Could Eliminate 300,000 Surgeries a YearBrightWater Medical’s ConvertX seeks FDA approval to revolutionize ureter procedure.June 20, 2016PharmaceuticalsFDA Seeks Clinical Trial DiversityFDA launches new campaign encouraging minorities to participate in clinical trials.June 17, 2016Medical Device/PackagingFDA Approves 'Assisted Bulimia' DeviceNew device removes already-eaten food from stomach before digestion.June 16, 2016PharmaceuticalsGoogle AI Group Takes on HealthcareGoogle’s DeepMind teams up with NHS on a suite of healthcare products.June 15, 2016PharmaceuticalsPharma Packager Sells for $1B+PE firm Partners Group purchases PCI Pharma Services.June 14, 2016Home$20-Billion Drug’s Patent UselessJudge says Merck lied about hepatitis C drug patent, overturns verdict against Gilead.June 13, 2016Previous PagePage 168 of 168Top StoriesMaterialsGreat Earth Expands Use of Fiber-Based Closures to Entire LineSwedish nutraceutical brand rolls out paper screw caps across all supplement jars, a first large-scale commercial use of Blue Ocean Closures’ molded fiber technology.Medical Device/PackagingThrough the Line Podcast: Med Device Sterilization Considerations Amid EPA RegulationRegulatoryEPR Compliance Deadlines are Looming for Packaging ProducersSupply ChainWhat Are The Challenges Applying GS1 Standards Globally?Sponsor ContentMore Than a Label: How ECLs Deliver Critical Value in Patient Adherence and Safety
